TMO 531.9 (+0.37%)
US8835561023Medical Diagnostics & ResearchDiagnostics & Research

Thermo Fisher Scientific (TMO) Competitor Comparison

We are evaluating the key criteria listed to compare Thermo Fisher Scientific (TMO) against its competitors in the Diagnostics & Research industry.

Performance 5 years - TMO ranking 12 / 58

These are the competitors of Thermo Fisher Scientific in the industry Diagnostics & Research ranked by performance 5 years
1. Natera NTRA
347.41
2. Medpace Holdings MEDP
336.31
3. RadNet RDNT
335.53
4. Lantheus Holdings LNTH
335.04
5. Meridian Bioscience VIVO
118.46
6. Twist Bioscience TWST
107.38
7. Danaher DHR
84.35
8. Mettler-Toledo MTD
72.88
9. Waters WAT
72.19
10. Agilent Technologies A
70.42
11. IDEXX Laboratories IDXX
69.13
12. Thermo Fisher Scientific TMO
68.23
13. Laboratory Corp of America Holdings LH
62.08
14. DarioHealth DRIO
61.4
15. Fulgent Genetics FLGT
53.79
16. Quest Diagnostics DGX
52.23
17. PerkinElmer PKI
48.44
18. DexCom DXCM
37.96
19. IQVIA Holdings IQV
36.5
20. Charles River Laboratories CRL
35.61
21. Icon ICLR
28.93
22. CareDx CDNA
21.75
23. Ortho Clinical Diagnostics Holdings OCDX
13.74
24. Heska HSKA
12.14
25. Co-Diagnostics CODX
6.45
26. Qiagen QGEN
2.24
27. Anixa Biosciences ANIX
-14.91
28. Syneos Health SYNH
-16.98
29. Bioventus BVS
-18.61
30. Inotiv NOTV
-21.68
31. Interpace Biosciences IDXG
-22.36
32. Exact Sciences EXAS
-24.18
33. Olink Holding OLK
-26.82
34. NeoGenomics NEO
-31.43
35. Myriad Genetics MYGN
-37.62
36. Sotera Health SHC
-51.48
37. Illumina ILMN
-53.69
38. Guardant Health GH
-55.08
39. Sera Prognostics SERA
-55.9
40. Personalis PSNL
-56.04
41. Neogen NEOG
-58.36
42. Enzo Biochem ENZ
-65.26
43. Pacific Biosciences of California PACB
-65.89
44. National Research NRC
-69.2
45. Psychemedics PMD
-73.59
46. Trinity Biotech TRIB
-77.37
47. Exagen XGN
-77.92
48. MaxCyte MXCT
-79.28
49. MDxHealth MDXH
-83.87
50. Precipio PRPO
-85.63
51. bioAffinity Technologies BIAF
-86.07
52. Global Cord Blood CO
-86.47
53. Biodesix BDSX
-89.55
54. Neuronetics STIM
-92.42
55. Aspira Womens Health AWH
-92.98
56. Organovo Holdings ONVO
-95.1
57. SeqLL SQL
-95.22
58. Prenetics Global PRE
-96.3

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.